scholarly journals Study on Fracture Healing with Small-Splint-Fixation Therapy by Near-Infrared Raman Spectroscopy

2013 ◽  
Vol 2013 ◽  
pp. 1-6 ◽  
Author(s):  
Hao Huang ◽  
Shangyuan Feng ◽  
Weiwei Chen ◽  
Yun Yu ◽  
Duo Lin ◽  
...  
Keyword(s):  
Raman Spectroscopy ◽  
Fracture Healing ◽  
Near Infrared ◽  
Collagen Matrix ◽  
Calcium Hydroxyapatite ◽  
Treated Group ◽  
The Other ◽  
Control Group ◽  
Surface Layers

In this study, near-infrared (NIR) Raman spectroscopy was explored to assess the incorporation of calcium hydroxyapatite (CHA~960cm−1) and other biochemical substances during the recovery of rabbits with complete radial fractures treated with or without small splints. 24 rabbits were randomy divided into two groups, one treated with small-splint-fixation therapy and the other without any intervention. The rabbits were sacrificed at 7, 15, 23, and 30 days after surgery, and the surface layers of the calluses in the fracture healing site from control and treated groups were routinely prepared for Raman spectroscopy. The prominent Raman bands were observed, including minerals at 430, 590, 960, 1003, and 1071 cm−1, protein at 856, 876, 1246, and 1667cm−1, and lipid at 1767cm−1. The carbonate-to-phosphate ratio (CO3toυ1PO4) and the mineral-to-matrix ratio (υ1PO4to amide I) were calculated from these normalized Raman bands. Comparison of theυ1PO4-to-amide I ratio for the control group with that of the treated group probably indicated that the small-splint-fixation therapy could be useful for the gradual mineralization of the collagen matrix during fracture healing.

scholarly journals INSIGHTS INTO THE ROLE OF MORUS ALBA IN REVERSING OBESITY-ASSOCIATED HEPATIC STEATOSIS AND RELATED METABOLIC DISORDER IN RATS

2016 ◽  
pp. 231
Author(s):  
Hanaa H. Ahmed ◽  
Fatehya M Metwally ◽  
Hend Rashad ◽  
Asmaa M Zaazaa
Keyword(s):  
Insulin Resistance ◽  
Hepatic Steatosis ◽  
Metabolic Disorder ◽  
Ethanolic Extract ◽  
Treated Group ◽  
Morus Alba ◽  
The Other ◽  
Obese Group ◽  
Control Group

<p>ABSTRACT<br />Objective: The goal of the present study was to examine the viability of Morus alba (M. alba) ethanolic extract in repression of obesity-associated<br />hepatic steatosis and related metabolic disorder; dyslipidemia, hyperinsulinemia, and glycemic status.<br />Methods: Adult female albino rats were randomly assigned into four groups, eight rats each as follows: Group (1) control group received standard<br />rodent diet for 24 weeks. The other three groups administered high cholesterol diet for 12 weeks and served as obese group, M. alba-treated group,<br />and simvastatin-treated group.<br />Results: The current results showed an increment in thoracic circumference (TCX) and abdominal circumferences (AC) as well as body mass index<br />(BMI) in obese group. In addition, dyslipidemia, hyperinsulinemia, hyperglycemia, and insulin resistance have been elucidated in obese group.<br />Moreover, hepatic malondialdehyde (MDA), nitric oxide (NO), serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and bilirubin<br />values were significantly increased in obese groups versus control group. On the other hand, administration of ethanolic extract of Morus alba or<br />simvastatin could significantly lessen BMI and in addition to improve dyslipidemia in obese group. Glucose, insulin levels, and insulin resistance value<br />in serum samples demonstrated a significant reduction in obese group upon treatment with M. alba ethanolic extract or simvastatin. Furthermore,<br />noticeable depletion in hepatic MDA, NO contents, serum ALT, AST activities, and serum bilirubin level was recorded as a result of treatment with<br />either ethanolic extract of M. alba or simvastatin. Histopathological examination of liver tissue showed ballooning degeneration in the hepatocytes<br />(hepatic steatosis) associated with inflammatory cells penetration in portal zone in obese group. Meanwhile, the treatment of obese groups with<br />ethanolic extract of M. alba or simvastatin was found to restore the structural organization of the liver.<br />Conclusion: The present findings provide a novel aspect for understanding of the role of M. alba against obesity-associated liver diseases and related<br />metabolic disorder. The mechanisms underlying these effects seem to depend on the hypolipidemic potential, anti-inflammatory property, and<br />antioxidant activity of its phytochemicals.<br />Keywords: Obesity, Morus alba, Dyslipidemia, Hyperinsulinemia, Hyperglycemia, Hepatic steatosis.</p>

The effect of deworming naturally infected heifers on liveweight gain, reproductive performance and fecal egg counts

1993 ◽  
Vol 73 (2) ◽  
pp. 287-293
Author(s):  
S. L. Boyles ◽  
L. J. Johnson ◽  
W. D. Slanger ◽  
B. J. Kreft ◽  
J. D. Kirsch
Keyword(s):  
Key Words ◽  
Reproductive Performance ◽  
Fecal Sample ◽  
Average Daily Gain ◽  
Treated Group ◽  
The Other ◽  
Control Group ◽  
Age At Puberty ◽  
Daily Gain

Twenty-six of 52 heifers with an average liveweight of 318 kg were dewormed by intraruminal injection of oxfendazole and placed in drylot on 31 January. The other 26 animals served as controls. All heifers were pastured starting on 14 June and the treatment heifers were dewormed in the same manner as at the start of the experiment (31 January) on 1 July and 31 July. The groups started out with similar total worm eggs per gram of fecal sample, but the dewormed heifers had fewer counts each month thereafter. The drylot average daily gain of the treated heifers was higher (P = 0.01) and less variable (P = 0.12) and by 29 May these animals were heavier by 11.7 kg (P = 0.10). The treated animals did not gain as fast on pasture (P = 0.20), but the gain continued to be less variable (P = 0.09). Age at puberty was not different. Number of open heifers in the treated group was 4 vs. 15% for the control group (P = 0.18). Deworming by intraruminal injection resulted in faster feedlot gains, more uniform gains during both drylot and pasture, reduced parasites and no abscess at injection sites. Key words: Anthelmintics, oxfendazole, cattle, heifers

Impact of mycotoxins and of a mycotoxin deactivator on alpacas grazing perennial ryegrass infected with wild endophyte (Neotyphodium spp.)

2010 ◽  
Vol 50 (9) ◽  
pp. 902 ◽  
Author(s):  
K. F. M. Reed ◽  
J. L. Vaughan ◽  
L. J. Cummins ◽  
D. D. Moore
Keyword(s):  
Perennial Ryegrass ◽  
Animal Health ◽  
Late Summer ◽  
Treated Group ◽  
The Other ◽  
Control Group ◽  
Liver Enzyme Activity ◽  
Early Autumn ◽  
Lolitrem B ◽  
The Difference

Liveweight gain, animal health and the effectiveness of a mycotoxin deactivator were studied on an old pasture that contained 61% perennial ryegrass. Sixty-seven percent of the ryegrass population was infected with endophyte (Neotyphodium spp.). The pasture was fenced into two halves and two groups of 28 alpaca male weaners were rotated between the two plots. Nine to 10 Suris and 18–19 Huacayas were allocated to each group. One group was fed a concentrate supplement (100 g/head per day) and the other was fed the same supplement to which was added the toxin deactivator, Mycofix® Plus (5 g/100 g). Mean liveweight gain on the low-quality pasture over late summer and early autumn was not significantly (P > 0.05) different between the groups. For the control group it was 41 g/day but individual rates of gain ranged from 67 to 0 g/day, depending on the severity of signs of perennial ryegrass toxicosis (r = 0.82, P < 0.001). Liveweight gain was independent of neurotoxic signs in the Mycofix® Plus treated group. Ergovaline concentration in perennial ryegrass varied from 0.43 to a peak in early autumn (March) of 1.05 mg/kg. Mean urine lysergol alkaloid concentration peaked in mid-summer (January) at 109 ng/mg creatinine (control group) and was consistently lower in the Mycofix® Plus group, although the difference approached significance (P = 0.06) only in March. Lolitrem B concentration in perennial ryegrass varied from 0.78 to 1.57 mg/kg. Neurotoxic signs in alpacas were observed throughout the study and peaked in early autumn, coinciding with peak lolitrem B concentration; at this time, 84% of alpacas exhibited neurotoxic signs. Over the 145-day study, the Mycofix® Plus treated group exhibited a lower mean rating of perennial ryegrass toxicosis signs (P < 0.05). Variation in liveweight gain and signs of toxicosis were not associated with significant differences in liver enzyme activity.

Three superoxide dismutase genes from Tetranychus cinnabarinus (Boisduval) involved in the responses to temperature and acaricide stresses

2019 ◽  
Vol 24 (1) ◽  
pp. 16 ◽  
Author(s):  
Tianrong Xin ◽  
Xiaoyue Li ◽  
Jiadong Yin ◽  
Xianyan Ye ◽  
Ji Wang ◽  
...  
Keyword(s):  
Superoxide Dismutase ◽  
Metal Binding ◽  
Expression Profiles ◽  
Treated Group ◽  
The Other ◽  
Control Group ◽  
Tetranychus Cinnabarinus ◽  
Expression Levels ◽  
Relative Expression ◽  
Significant Difference

In almost all aerobic organisms, the superoxide dismutase (SOD) is considered as an important antioxidant enzyme regulating oxidative stress. Tetranychus cinnabarinus is an economically important polyphagous pest mite, which harms a variety of economic crops and ornamental plants. In the present study, the full-length cDNA sequences of cytoplasmic Cu/ZnSOD (TcSOD1), extracellular Cu/ZnSOD (TcSOD2) and mitochondrial MnSOD (TcSOD3) from T. cinnabarinus were cloned by combining RT-PCR and rapid amplification of cDNA ends (RACE). The corresponding open reading frames (ORFs) encode three putative polypeptides of 152, 232, 225 amino acid residues, respectively. These sequences share the conserved SOD functional domains, signature motifs and metal binding sites. Multiple alignment analysis revealed that cytosolic Cu/ZnSOD and mitochondrial MnSOD sequences are relatively conserved, while extracellular Cu/ZnSODs are more diverse. Phylogenetic analysis showed that SODs are organized into two major clades, corresponding to Cu/ZnSODs, and MnSODs. Cu/ZnSODs are subdivided into two branches, one being composed of cytoplasmic Cu/ZnSODs, and the other corresponding to extracellular Cu/ZnSODs. Expression profiles of the three genes were determined at different temperatures (4°C, 25°C, and 40°C) for 2 hours. The relative expression of TcSOD1, TcSOD2, and TcSOD3 were significantly down-regulated (0.344-, 0.287-, and 0.358-fold, respectively) at 4°C compared to 25°C (P<0.05). The relative expression levels of TcSOD1 and TcSOD2 genes were significantly down-regulated at 40°C (0.481- and 0.291-fold less than in the control group, respectively) (P<0.05), while there was no significant difference in the relative expression level of TcSOD3(P>0.05). Moreover, expression levels were altered after exposition to different acaricides. TcSOD1, TcSOD2, and TcSOD3 were significantly down-regulated (0.450-, 0.147- and 0.663-fold decreases, respectively) in the abamectin-treated group (P<0.05). TcSOD1 and TcSOD2 were down-regulated, in the fenpropathrin-treated group with 0.794- and 0.201-fold decreases, respectively. On the other hand, the expression of TcSOD3 was significantly increased (P<0.05), being 2.774-fold higher than in the control group. The expression of TcSOD2 was significantly down-regulated both the propargite- and cyflumetofen-treated groups (0.655- and 0.397-fold, respectively) (P<0.05). The data reported here indicate that SODs from T. cinnabarinus may play different and vital roles in anticipating the effects of oxidative damage at extreme temperatures and under different acaricides stress.

The Effects of Halofuginone on Wound Healing in the Rat Nasal Mucosa

2019 ◽  
Vol 34 (1) ◽  
pp. 9-15 ◽  
Author(s):  
Seyit Mehmet Ceylan ◽  
Erdal Uysal ◽  
Mehmet Sokucu ◽  
Efe Sezgin ◽  
Mahmut Alper Kanmaz ◽  
...  
Keyword(s):  
Wound Healing ◽  
Nasal Mucosa ◽  
Goblet Cell ◽  
Cell Formation ◽  
Treated Group ◽  
Potential Effect ◽  
The Other ◽  
Parasitic Infections ◽  
Control Group ◽  
Cell Hyperplasia

Background Halofuginone is an alkaloid febrifugine analogue and bioactive molecule that was isolated incidentally from the Dichroa febrifuga plant. The therapeutic efficacy of halofuginone in parasitic infections, scleroderma, inflammation, and fibrosis-related diseases, as well as in some types of cancer, has been previously reported. The effects of halofuginone on nasal mucosal damage are not yet known. Objective The aim of this study was to investigate the potential effect of topically applied halofuginone on wound healing in the mechanically injured nasal mucosa of rats. Methods A unilateral mucosal wound was created in the nasal cavity of 32 rats (aged 4 weeks) using the brushing technique. These rats were randomly divided into 4 groups. Although the control group did not receive an intervention, a dry pad, a saline-impregnated pad, or a pad impregnated with halofuginone were placed in the rats of the other 3 groups and left for 5 minutes. Rats were sacrificed on the 14th day, and a histological examination was performed. The nasal mucosa was assessed via hematoxylin-eosin and Masson’s trichrome staining. Results There were no statistically significant differences in epithelial thickness, inflammation, goblet cell formation, and epithelial disarray values between the halofuginone group and the control group ( P > .05). The subepithelial thickness was significantly decreased in the saline-treated group and the halofuginone-treated group ( P < .05), but a significantly lower level of subepithelial fibrosis was only observed in the halofuginone group compared to the other groups ( P < .05). Conclusions Topical halofuginone administration reduces the development of fibrosis and subepithelial edema after experimentally induced nasal mucosal injury, but it does not exert therapeutic or preventive effects on epithelial damage, inflammation, and goblet cell hyperplasia.

THE EFFECTS OF NICOTINE ON FRACTURE HEALING: AN EXPERIMENTAL STUDY

2002 ◽  
Vol 06 (02) ◽  
pp. 119-125
Author(s):  
Mustafa Agca ◽  
Ibrahim Tuncay ◽  
Nihat Tosun ◽  
Fuat Akpinar
Keyword(s):  
Fracture Healing ◽  
Healing Process ◽  
Final Analysis ◽  
Treated Group ◽  
Control Group ◽  
Significant Difference ◽  
Negative Effect ◽  
Treatment Research ◽  
Group B ◽  
Transverse Fractures

This study is aimed to evaluate treatment research the effects of nicotine on fracture healing. Thirty rats were used. Nicotine was injected subcutanously at a dosage of 2 mg/kg/day to group A and 4 mg/kg/day to group B. Control group (group C) received 0.5 ml/kg/day saline solution. Three weeks later, transverse fractures were performed on to the left ulnar and radial bones for each animal. Animals were designed to one of two follow-up groups which were euthanized either 2 or 3 weeks. On the 14th day of fracture, randomly chosen five rats from each group of A, B and C were sacrificed. At the 21st day of fracture, same procedure performed for all remaining rats. Both had surgical and histopathological evaluation were performed. Transverse fractures performed on the 21st day of study were confirmed by direct radiograms. One rat died spontaneously before completing the study was therefore excluded from the final analysis. The results indicate that healing process proceeds in each group. There was no significant difference in fracture healing between groups A and B two weeks after the fracture. However, fracture healing was significantly delayed in nicotine treated group comparing to control group. We continue to support the notion that nicotine has a negative effect on fracture healing.

Effects of Achievement Motivation Training on Academic Performance of Underachievers

1980 ◽  
Vol 47 (2) ◽  
pp. 567-574 ◽  
Author(s):  
Allan Markle ◽  
Roger C. Rinn ◽  
Brenda Goodwin
Keyword(s):  
Academic Performance ◽  
Training Program ◽  
Achievement Motivation ◽  
Treated Group ◽  
The Other ◽  
Control Group ◽  
Present Program ◽  
Treatment Control ◽  
Treatment Control Group

In an attempt to help underachieving students improve academic performance, an Achievement Motivation Training program was developed. Although similar to other programs focusing on achievement motivation, substantial differences exist, particularly since the present program is presented in an outpatient format rather than integrated into the classroom. 54 students (Grades 3 to 11), referred by their counselors, were subjects; half of these completed our Achievement Motivation Training program, the other half served as a no-treatment control group. The treated group showed a significant improvement in grades from before training to follow-up as well as significantly greater improvement than the control group. Also, a new methodology was offered and tested, demonstrating that a no-treatment group may not be necessary when grades are the primary dependent variable.

Renal response to vasopressin and indomethacin in cisplatin-treated rats

1987 ◽  
Vol 73 (4) ◽  
pp. 377-381 ◽  
Author(s):  
Christopher J. Lote ◽  
Ernest S. Harpur ◽  
Andrew Thewles ◽  
Donna J. Phipps
Keyword(s):  
Body Weight ◽  
Single Dose ◽  
Treated Group ◽  
Urine Flow ◽  
The Other ◽  
Control Group ◽  
Fischer 344 ◽  
Antidiuretic Effect ◽  
Natriuretic Effect ◽  
Observation Period

1. Cisplatin [6 mg/kg body weight, in 0.9% (w/v) NaCl] was injected intraperitoneally as a single dose to two groups of rats (Fischer 344 strain). Two further groups of rats, injected intraperitoneally with an equivalent volume of 0.9% (w/v) NaCl, were used as controls. The cisplatin-treated rats developed a pronounced polyuria which did not recover during an 18 week observation period. 2. After 21 weeks, one group of the cisplatin-treated animals received a 6 h infusion of 2.5% d-glucose. Vasopressin (60 μ-units min−1 100 g−1 body weight) was incorporated into the infusate for the final 2 h. A control group of animals received an identical infusion. One week later the other group of cisplatin-treated rats received a 6 h infusion of 0.9% (w/v) NaCl. Indomethacin was incorporated into the infusate for 15 min, at 3 h 52.5 min, to deliver a dose of 10 mg/kg body weight. A control group again received an identical infusion. 3. Cisplatin did not impair the antidiuretic effect of vasopressin, but it reduced the natriuretic effect of vasopressin, and also impaired the ability of the animals to produce concentrated urine. 4. Cisplatin did not alter basal PGE2 excretion, or the reduction in PGE2 excretion induced by indomethacin. However, the urine flow in the cisplatin-treated group did not fall after indomethacin, whereas there was a fall in urine flow in the control group.

MELATONIN ON ENDOCRINE DNA CHANGES IN FEMALE RATS AT INCREASING AGES

1971 ◽  
Vol 68 (3) ◽  
pp. 597-604 ◽  
Author(s):  
D. V. Singh ◽  
C. W. Turner
Keyword(s):  
Body Weight ◽  
Treated Group ◽  
The Other ◽  
Female Rats ◽  
Unit Weight ◽  
Control Group ◽  
Uterine Weight ◽  
Endocrine Glands ◽  
Sprague Dawley ◽  
Total Dna

ABSTRACT Sixty female Sprague-Dawley-Rolfsmeyer rats were divided equally into three groups, twenty in each group at 25 days of age. One half of each group serving as controls received saline, the other half received 100 ftg melatonin/100 g body weight at 25, 35. and 45 days of age, for 10 days. They were killed 24 hours after the last injection. Pituitaries. ovaries, uteri, adrenals and thyroids were collected and weighed. DNA determination by the method described by Webb Se Levy (1955) was used for ovaries, uteri and adrenals only. Pituitary weight was not affected much by the treatment of melatonin. Thyroid weight increased: adrenals, ovaries and uterine weight decreased gradually up to 55 days in melatonin treated group as compared to the control. Ovarian total DNA increased significantly at 35 days of age, but significantly decreased at 45 and 55 days of age in melatonin treated group as compared to the corresponding controls. No difference in total DNA in adrenals was found in melatonin treated animals as compared to control group at any age. The total DNA of the uteri increased 29 % at 35 days of age but decreased at 55 days of age by 14%. These data also show that the DNA/mg of endocrine glands dry fat free tissue decreased with increasing age suggesting a reduction in functional cells per unit weight in older animals.

Bioartificial Liver: Implanted Artificial Cells Microencapsulated Living Hepatocytes Increases Survival of Liver Failure Rats

1986 ◽  
Vol 9 (5) ◽  
pp. 335-336 ◽  
Author(s):  
H. Wong ◽  
T.M.S. Chang
Keyword(s):  
Liver Failure ◽  
Fulminant Hepatic Failure ◽  
Hepatic Failure ◽  
Treated Group ◽  
Bioartificial Liver ◽  
The Other ◽  
Control Group ◽  
Artificial Cells ◽  
Mean Diameter ◽  
Grade Ii

Suspension of living hepatocytes were microencapsulated inside 300 micron mean diameter alginate artificial cells. The galactosamine fulminant hepatic failure rat model was used. 48 hours after the injection of galactosamine, grade II coma hepatic failure rats were divided into pairs. One of the pair was randomly chosen for the control group, and the other for the treated group. Each rat in the control group received one peritoneal injection of microcapsules containing no hepatocytes. Each rat in the treated group received one peritoneal injection of microcapsules containing hepatocytes. The survival of the treated group is significantly higher than the control group.

Sign in / Sign up

Export Citation Format

Share Document